Follow the GlobeStar Therapeutics Corp stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €124k. The latest transaction was disclosed on 4 April 2023 (J). Among the most active insiders: KATZAROFF JAMES C. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
GlobeStar Therapeutics Corp 是一家专注于开发治疗慢性疾病的创新疗法的公司。该公司在 XNAS 市场上市。